Coalition for Kidney Health

In 2020, NKF launched the Coalition for Kidney Health, a multi-stakeholder group of partners working to transform the landscape of chronic kidney disease (CKD) by:

Generating awareness of CKD;
Increasing screening of at-risk patients;
Driving forward high-quality, coordinated care focused on delaying CKD progression.

Policy Priorities

CKD quality measurement including advocacy for the Kidney Health Evaluation Measure
Development of a national public health strategy for kidney disease
CKD screening recommendations
Improve equity in CKD public health and health care

Membership

Academy of Nutrition and Dietetics
American Heart Association
AstraZeneca
Bayer
Boehringer Ingelheim
Elevance Health
National Kidney Foundation
Novartis
Optum Labs
Renal Physicians Association
Travere Therapeutics
Vertex Pharmaceuticals
Voice of the Patient

Recent Activity

September 2023 - Proposed edits to the United States Preventive Services Task Force CKD Research Plan emphasizing the need to appropriately target limited healthcare resources where they'll have the greatest effect.

September 2023 - Comment letter on CY 2024 Physician Fee Schedule highlighting opportunities to improve kidney disease awareness, diagnosis, and management.

July 2023 - Comment letter to HHS Secretary and CMS Administrator on importance of ensuring access to Medicaid services for CKD patients.

March 2023 - Appropriations letter to House Labor, Health and Human Services, Education, and Related Agencies FY 2024 appropriations bill.

February 2023 - Comment letter on USPSTF CKD screening draft research plan.

Please contact Ignacio Alvarez at ignacio.alvarez@kidney.org if you are interested in membership.